The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Open accessAbstract
Treatment and management of diseases of the posterior segment of the eye such as diabetic retinopathy, retinoblastoma, retinitis pigmentosa, and choroidal neovascularization is a challenging task due to the anatomy and physiology of ocular barriers. For instance, traditional routes of drug delivery for therapeutic treatment are hindered by poor intraocular penetration and/or rapid ocular elimination. One possible approach to improve ocular therapy is to employ nanotechnology. Nanomedicines, products of nanotechnology, having at least one dimension in the nanoscale include nanoparticles, micelles, nanotubes, and dendrimers, with and without targeting ligands, are making a significant impact in the fields of ocular drug delivery, gene delivery, and imaging, the focus of this review. Key applications of nanotechnology discussed in this review include a) bioadhesive nanomedicines; b) functionalized nanomedicines that enhance target recognition and/or cell entry; c) nanomedicines capable of controlled release of the payload; d) nanomedicines capable of enhancing gene transfection and duration of transfection; f) nanomedicines responsive to stimuli including light, heat, ultrasound, electrical signals, pH, and oxidative stress; g) diversely sized and colored nanoparticles for imaging, and h) nanowires for retinal prostheses. Additionally, nanofabricated delivery systems including implants, films, microparticles, and nanoparticles are described. Although the above nanomedicines may be administered by various routes including topical, intravitreal, intravenous, transscleral, suprachoroidal, and subretinal routes, each nanomedicine should be tailored for the disease, drug, and site of administration. In addition to the nature of materials used in nanomedicine design, depending on the site of nanomedicine administration, clearance and toxicity are expected to differ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Kadam, R. S., Tyagi, P., Edelhauser, H. F., & Kompella, U. B. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.025 · Cited by 41
Self-citationRetractedSclera-Choroid-RPE Transport of Eight β-Blockers in Human, Bovine, Porcine, Rabbit, and Rat Models
Kadam, R. S., Cheruvu, N. P. S., Edelhauser, H. F., & Kompella, U. B. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6233 · Cited by 32
Self-citationRetractedMatsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823 · cited 1×
“…perhaps more specific to the route of delivery, target tissue, and the nanoparticle composition, include inflammation, immunestimulation (Dobrovolskaia and McNeil, 2007; Zolnik et al., 2010), immunosuppression, aggregation, accumulation in non-target tissues, membrane disruption…”
BackgroundMicroneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,346
Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.002 · Cited by 1,026
Dissolving microneedles for transdermal drug delivery
Lee, J. W., Park, J.-H., & Prausnitz, M. R. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.048 · Cited by 968
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914 · cited 1×
“…to the route of delivery, target tissue, and the nanoparticle composition, include inflammation, immunestimulation (Dobrovolskaia and McNeil, 2007; Zolnik et al., 2010), immunosuppression, aggregation, accumulation in non-target tissues, membrane disruption (Panessa-Warren et al., 2009),…”
BackgroundPractical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
Kragh-Hansen, U., Chuang, V. T. G., & Otagiri, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.695 · Cited by 892
McAllister, D. V., Wang, P. M., Davis, S. P., Park, J.-H., Canatella, P. J., Allen, M. G., & Prausnitz, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331316100 · Cited by 859 · cited 2×
“…(Miyano et al., 2005) (Kolli and Banga, 2008), dextrin (Ito et al., 2006), ceramic (Ovsianikov et al., 2007), stainless steel (Verbaan et al., 2008), galactose (Donnelly et al., 2009), and various polymers (McAllister et al., 2003) (Park et al., 2005, 2006) (Pérennès et al., 2006) may also be used.”
BackgroundNanoparticles: pharmacological and toxicological significance
Medina, C., Santos‐Martinez, M. J., Radomski, A., Corrigan, O. I., & Radomski, M. W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707130 · Cited by 738
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Nanotechnology for the biologist
McNeil, S. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205074 · Cited by 613
Lack of Pain Associated with Microfabricated Microneedles
Kaushik, S., Hord, A. H., Denson, D. D., McAllister, D. V., Smitra, S., Allen, M. G., & Prausnitz, M. R. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200102000-00041 · Cited by 576
A BioMEMS Review: MEMS Technology for Physiologically Integrated Devices
Grayson, A. C. R., Shawgo, R. S., Johnson, A. M., Flynn, N. T., Li, Y., Cima, M. J., & Langer, R. (2004) · Proceedings of the IEEE · doi:10.1109/jproc.2003.820534 · Cited by 562
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502 · cited 1×
“Polyethyleneglycol, the component that forms the micellar shell, is usually chosen such that its molecular weight is higher than that of the hydrophobic core forming molecule (Kwon, 2003).”
BackgroundPolymer Microneedles for Controlled-Release Drug Delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0028-9 · Cited by 493
PEG-based micelles as carriers of contrast agents for different imaging modalities
Torchilin, V. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00019-4 · Cited by 470
Schipper, M. L., Iyer, G., Koh, A. L., Cheng, Z., Ebenstein, Y., Aharoni, A., Keren, S., Bentolila, L. A., Li, J., Rao, J., et al. (2009) · Small · doi:10.1002/smll.200800003 · Cited by 452
A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength
Hassan, E. E., & Gallo, J. M. (1990) · Pharmaceutical Research · doi:10.1023/a:1015812615635 · Cited by 438
Chitosan and its derivatives as intestinal absorption enhancers
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00180-6 · Cited by 430
Hollow Metal Microneedles for Insulin Delivery to Diabetic Rats
Davis, S. P., Martanto, W., Allen, M. G., & Prausnitz, M. R. (2005) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2005.845240 · Cited by 406
Innate immunity and pulmonary host defense: Lung innate immunity
Zhang, P., Summer, W. R., Bagby, G. J., & Nelson, S. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917306.x · Cited by 404
Applications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
Nanogels for Oligonucleotide Delivery to the Brain
Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 377
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
Trivedi, R., & Kompella, U. B. (2010) · Nanomedicine · doi:10.2217/nnm.10.10 · Cited by 358 · cited 1×
“Similarly, based on the ambient solvent and the type of amphiphilic molecule used, different structures of micelles predominate in the formulation, such as standard, reverse and unimolecular micelles (Trivedi and Kompella, 2010).”
BackgroundSelf-citation(2000) · PubMed · Cited by 358
Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis
Young, S., Larkin, G., Branley, M., & Lightman, S. (2001) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2001.00360.x · Cited by 352
Suprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330 · cited 7×
“Patel and colleagues used hollow microneedles to deliver nanoparticle and microparticle suspensions in the suprachoroidal space of rabbit, porcine, and human ex-vivo eyes (Patel et al., 2011).”
BackgroundInfluentialSchnitzer, J. E., & Oh, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37571-3 · Cited by 324
Ocular biomaterials and implants
Lloyd, A. W., Faragher, R. G. A., & Denyer, S. P. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00237-4 · Cited by 313
Coated Microneedles for Drug Delivery to the Eye
Jiang, J., Gill, H. S., Ghate, D., McCarey, B. E., Patel, S. R., Edelhauser, H. F., & Prausnitz, M. R. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0066 · Cited by 286
de Salamanca, A. E., Diebold, Y., Calonge, M., Garci´a-Vazquez, C., Callejo, S., Vila, A., & Alonso, M. J. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0495 · Cited by 286
Recent Advances in Ophthalmic Drug Delivery
Kompella, U. B., Kadam, R. S., & Lee, V. H. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.40 · Cited by 285
Self-citationMoghimi, S. M., Porter, C. J. H., Muir, I. S., Illum, L., & Davis, S. S. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91869-e · Cited by 282
McAllister, K., Sazani, P., Adam, M., Cho, M. J., Rubinstein, M., Samulski, R. J., & DeSimone, J. M. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027759q · Cited by 273
Nanoparticle Technology for Drug Delivery
(2006) · CRC Press eBooks · doi:10.1201/9780849374555 · Cited by 264
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Pitka¨nen, L., Ranta, V.-P., Moilanen, H., & Urtti, A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1051 · Cited by 261 · cited 2×
“Pitkanen and colleagues demonstrated that bovine choroid-RPE is 10–100 times less permeable to hydrophilic and macromolecular compounds compared to the sclera (Pitkanen et al., 2005).”
Backgroundvan der Merwe, S. M., Verhoef, J. C., Verheijden, J. H. M., Kotzé, A. F., & Junginger, H. E. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.023 · Cited by 260
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
Self-citationSugar Micro Needles as Transdermic Drug Delivery System
Miyano, T., Tobinaga, Y., Kanno, T., Matsuzaki, Y., Takeda, H., Wakui, M., & Hanada, K. (2005) · Biomedical Microdevices · doi:10.1007/s10544-005-3024-7 · Cited by 256
Ashok, B., Arleth, L., Hjelm, R. P., Rubinstein, I., & Önyüksel, H. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20150 · Cited by 255
Kompella, U. B., Bandi, N., & Ayalasomayajula, S. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0791 · Cited by 239
Self-citationImproved piercing of microneedle arrays in dermatomed human skin by an impact insertion method
Verbaan, F. J., Bal, S. M., van den Berg, D. J., Dijksman, J. A., van Hecke, M., Verpoorten, H., van den Berg, A., Luttge, R., & Bouwstra, J. A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.009 · Cited by 233
Characterization of Solid Maltose Microneedles and their Use for Transdermal Delivery
Kolli, C. S., & Banga, A. K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9350-0 · Cited by 216
Amrite, A. C., & Kompella, U. B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.12.0005 · Cited by 212
Self-citationIntrascleral Drug Delivery to the Eye Using Hollow Microneedles
Jiang, J., Moore, J. S., Edelhauser, H. F., & Prausnitz, M. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9756-3 · Cited by 208
Yang, H., Tyagi, P., Kadam, R. S., Holden, C. A., & Kompella, U. B. (2012) · ACS Nano · doi:10.1021/nn301873v · Cited by 207
Self-citationSingh, S. R., Grossniklaus, H. E., Kang, S. J., Edelhauser, H. F., Ambati, B. K., & Kompella, U. B. (2009) · Gene Therapy · doi:10.1038/gt.2008.185 · Cited by 204
Self-citationEl-Remessy, A. B., Behzadian, M. A., Abou-Mohamed, G., Franklin, T., Caldwell, R. W., & Caldwell, R. B. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64332-5 · Cited by 203
Ovsianikov, A., Schlie, S., Ngezahayo, A., Haverich, A., & Chichkov, B. N. (2007) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.57 · Cited by 194
Iezzi, R., Guru, B. R., Glybina, I. V., Mishra, M. K., Kennedy, A., & Kannan, R. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.010 · Cited by 192
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection
Weijtens, O., Feron, E. J., Schoemaker, R. C., Cohen, A. F., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., & van Meurs, J. C. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00129-4 · Cited by 188
Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein
Vogel, S. M., Minshall, R. D., Pilipović, M., Tiruppathi, C., & Malik, A. B. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.6.l1512 · Cited by 184
Binding of Drugs to Eye Melanin Is Not Predictive of Ocular Toxicity
Leblanc, B., Jezequel, S., Davies, T., Hanton, G., & Taradach, C. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1243 · Cited by 179
Arrays of hollow out-of-plane microneedles for drug delivery
Stoeber, B., & Liepmann, D. (2005) · Journal of Microelectromechanical Systems · doi:10.1109/jmems.2005.844843 · Cited by 178
Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion
Meng, J., Sturgis, T. F., & Youan, B.-B. C. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.06.007 · Cited by 172
Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment
Olsen, T. W., Feng, X., Wabner, K., Conston, S. R., Sierra, D. H., Folden, D. V., Smith, M. E., & Cameron, J. D. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.045 · Cited by 171 · cited 3×
“…a potential site of drug delivery for the treatment of posterior segment ocular disorders (Einmahl et al., 2002; Gilger et al., 2006; Gilger et al., 2010; Jiang et al., 2007; Jiang et al., 2009; Olsen et al., 2006; Olsen et al., 2011; Patel et al., 2011; Peden et al., 2011; Touchard et al., 2012).”
BackgroundMethodPérennès, F., Marmiroli, B., Matteucci, M., Tormen, M., Vaccari, L., & Fabrizio, E. D. (2006) · Journal of Micromechanics and Microengineering · doi:10.1088/0960-1317/16/3/001 · Cited by 168
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Carrasquillo, K. G., Ricker, J. A., Rigas, I. K., Miller, J. W., Gragoudas, E. S., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.01-1156 · Cited by 163
Amrite, A. C., Ayalasomayajula, S. P., Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0531 · Cited by 162
Self-citationHornof, M., Weyenberg, W., Ludwig, A., & Bernkop-Schnürch, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00135-4 · Cited by 162
Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling
Ranta, V.-P., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.025 · Cited by 160
Ayalasomayajula, S. P., & Kompella, U. B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02793-0 · Cited by 159
Self-citationProcessing difficulties and instability of carbohydrate microneedle arrays
Donnelly, R. F., Morrow, D. I. J., Singh, T. R. R., Migalska, K., McCarron, P. A., O'Mahony, C., & Woolfson, A. D. (2009) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040902882280 · Cited by 159
A passive MEMS drug delivery pump for treatment of ocular diseases
Lo, R., Li, P.-Y., Saati, S., Agrawal, R. N., Humayun, M. S., & Meng, E. (2009) · Biomedical Microdevices · doi:10.1007/s10544-009-9313-9 · Cited by 158
Effect of Particle Size of Polymeric Nanospheres on Intravitreal Kinetics
Sakurai, E., Ozeki, H., Kunou, N., & Ogura, Y. (2000) · Ophthalmic Research · doi:10.1159/000055638 · Cited by 156
Ciechanover, A. J., Schwartz, A. L., & Lodish, H. F. (1983) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240230111 · Cited by 153
Howard, D. B., Powers, K., Wang, Y., & Harvey, B. K. (2008) · Virology · doi:10.1016/j.virol.2007.10.007 · Cited by 149
Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs
Holden, C. A., Tyagi, P., Thakur, A., Kadam, R. S., Jadhav, G., Kompella, U. B., & Yang, H. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.08.018 · Cited by 143
Self-citationAyalasomayajula, S. P., & Kompella, U. B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.019 · Cited by 141
Self-citationHuman serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene.
Mo, Y., Barnett, M. E., Takemoto, D. J., Davidson, H. J., & Kompella, U. B. (2007) · PubMed Central · Cited by 133
Self-citationGong, X., Peng, S., Wen, W., Sheng, P., & Li, W. (2008) · Advanced Functional Materials · doi:10.1002/adfm.200801315 · Cited by 131
Kim, H. C., Robinson, M. R., Lizak, M. J., Tansey, G., Lutz, R. J., Yuan, P., Wang, N. S., & Csaky, K. G. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0091 · Cited by 129
Microneedle Insertion Force Reduction Using Vibratory Actuation
Yang, M., & Zahn, J. D. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000042046.07678.2e · Cited by 128
Maurice, D. M., & Polgar, J. (1977) · Experimental Eye Research · doi:10.1016/0014-4835(77)90136-1 · Cited by 127
Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes
Acheampong, A., Shackleton, M., John, B. A., Burke, J. E., Wheeler, L. A., & Tang-Liu, D. D.-S. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.421 · Cited by 126
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Self-citationDrug Delivery to the Posterior Segment from Drops
Maurice, D. M. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00326-0 · Cited by 124
Ladas, I. D., Karagiannis, D. A., ROUVAS, A. A., Kotsolis, A. I., LIOTSOU, A., & Vergados, I. A. (2009) · Retina · doi:10.1097/iae.0b013e31819a5f98 · Cited by 124
Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0404 · Cited by 121
Self-citationNanoparticles for retinal gene therapy
Conley, S. M., & Naash, M. I. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.004 · Cited by 117
Weijtens, O., van der Sluijs, F. A., Schoemaker, R. C., Lentjes, E. G. W. M., Cohen, A. F., Romijn, F. P. H. T. M., & MEURS, J. C. V. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70131-x · Cited by 115
Genetic transformation of nematodes using arrays of micromechanical piercing structures.
Hashmi, S., Ling, P., Hashmi, G. P., Reed, M., Gaugler, R. R., & Trimmer, W. (1995) · PubMed · Cited by 115
Subconjunctival Nanoparticle Carboplatin in the Treatment of Murine Retinoblastoma
Kang, S. J. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.185 · Cited by 113
Ocular Nanoparticle Toxicity and Transfection of the Retina and Retinal Pigment Epithelium
Prow, T. W., Bhutto, I., Kim, S. Y., Grebe, R., Merges, C., McLeod, D. S., Uno, K., Mennon, M., Rodriguez, L., Leong, K., et al. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.003 · Cited by 111 · cited 2×
“These responses could further lead to vitreal haze, epithelial damage, membrane opacity, hemorrhage, fibrosis, and retinal damages such as traction, thickening, tear, fold and degeneration in the back of the eye (Prow et al., 2008).”
BackgroundA Novel Bioerodible Deep Scleral Lamellar Cyclosporine Implant for Uveitis
Gilger, B. C., Salmon, J. H., Wilkie, D. A., Cruysberg, L. P. J., Kim, J., Hayat, M., Kim, H., Kim, S. J., Yuan, P., Lee, S. S., et al. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1540 · Cited by 111
Short-term complications of intravitreal injections of triamcinolone and bevacizumab
Jonas, J. B., Spandau, U. H., & Schlichtenbrede, F. C. (2008) · Eye · doi:10.1038/eye.2008.10 · Cited by 108
Lehr, C., Bouwstra, J. A., Kok, W., de Boer, A. G., Tukker, J. J., Verhoef, J. C., Breimer, D. D., & Junginger, H. E. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb03633.x · Cited by 107
Olsen, T. W., Feng, X., Wabner, K., Csaky, K., Pambuccian, S., & Cameron, J. D. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6291 · Cited by 106 · cited 4×
“Olsen and colleagues used microcannulation injections to successfully deliver bevacizumab in vivo into the suprachoroidal space of porcine eyes (Olsen et al., 2011).”
BackgroundInfluentialEffect of Eye Pigmentation on Transscleral Drug Delivery
Cheruvu, N. P. S., Amrite, A. C., & Kompella, U. B. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0214 · Cited by 103
Self-citationEvaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.
Einmahl, S., Savoldelli, M., D'Hermies, F., Tabatabay, C., Gurny, R., & Béhar‐Cohen, F. (2002) · PubMed · Cited by 102
Fujisawa, T., Miyai, H., Hironaka, K., Tsukamoto, T., Tahara, K., Tozuka, Y., Ito, M., & Takeuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.024 · Cited by 98
Luo, L., Zhang, X., Hirano, Y., Tyagi, P., Barabás, P., Uehara, H., Miya, T. R., Singh, N., Archer, B. J., Qazi, Y., et al. (2013) · ACS Nano · doi:10.1021/nn305958y · Cited by 98
Self-citationPark, K., Chen, Y., Hu, Y., Mayo, A. S., Kompella, U. B., Longeras, R., & Ma, J. (2009) · Diabetes · doi:10.2337/db08-1327 · Cited by 97
Self-citationGilger, B. C., Wilkie, D. A., Clode, A. B., McMullen, R. J., Lassaline, M. E., Komáromy, A. M., Brooks, D. E., & Salmon, J. H. (2010) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2010.00807.x · Cited by 96
Misra, G. P., Singh, R. S., Alemán, T. S., Jacobson, S. G., Gardner, T. W., & Lowe, T. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.025 · Cited by 95
Saishin, Y., Silva, R. L., Saishin, Y., Callahan, K. P., Schoch, C., Ahlheim, M., Lai, H. C., Kane, F. E., Brazzell, R. K., Bodmer, D., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0600 · Cited by 94
Pharmacokinetics of Intraocular Drug Delivery by Periocular Injections Using Ocular Fluorophotometry
Ghate, D. A., Brooks, W., McCarey, B. E., & Edelhauser, H. F. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0954 · Cited by 93
Subconjunctival Carboplatin in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
VANQUILL, K., Dioguardi, P. K., TONG, C., Gilbert, J. A., AABERGJR, T., Grossniklaus, H. E., EDELHAUSER, H., & OBRIEN, J. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.060 · Cited by 91
Weijtens, O., Schoemaker, R. C., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., Cohen, A. F., & van Meurs, J. C. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00344-4 · Cited by 90
Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs
Thanou, M., Verhoef, J. C., Verheijden, J. H. M., & Junginger, H. E. (2001) · Pharmaceutical Research · doi:10.1023/a:1011092613951 · Cited by 87
Dexamethasone Concentration in Vitreous and Serum After Oral Administration
Weijtens, O., Schoemaker, R. C., Cohen, A. F., Romijn, F. P. H. T. M., Lentjes, E. G. W. M., van Rooij, J., & van Meurs, J. C. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00003-8 · Cited by 87
Durairaj, C., Kadam, R. S., Chandler, J., Hutcherson, S. L., & Kompella, U. B. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5388 · Cited by 86
Self-citationRelevance of Drug-Melanin Interactions to Ocular Pharmacology and Toxicology
SALAZAR-BOOKAMAN, M. M., Wainer, I. W., & Patil, P. N. (1994) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1994.10.217 · Cited by 86
Ottiger, M., Thiel, M. A., Feige, U., Lichtlen, P., & Urech, D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2372 · Cited by 85
Functionalized STAT1 siRNA Nanoparticles Regress Rheumatoid Arthritis in A Mouse Model
Scheinman, R. I., Trivedi, R., Vermillion, S., & Kompella, U. B. (2011) · Nanomedicine · doi:10.2217/nnm.11.90 · Cited by 84
Self-citationMovement of Albumin and Dextran Through the Sclera
Bill, A. (1965) · Archives of Ophthalmology · doi:10.1001/archopht.1965.00970040250024 · Cited by 82
Ophthalmic light sensitive nanocarrier systems
Christie, J. G., & Kompella, U. B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.005 · Cited by 81
Self-citationPheomelanin as a Binding Site for Drugs and Chemicals
Mårs, U., & LARSSON, B. S. (1999) · Pigment Cell Research · doi:10.1111/j.1600-0749.1999.tb00760.x · Cited by 78
Pan, C. K., Durairaj, C., Kompella, U. B., Agwu, O., Oliver, S. C. N., Quiroz-Mercado, H., Mandava, N., & Olson, J. L. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0158 · Cited by 78
Self-citationModeling of Corneal and Retinal Pharmacokinetics after Periocular Drug Administration
Amrite, A. C., Edelhauser, H. F., & Kompella, U. B. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0593 · Cited by 78
Self-citationCruysberg, L. P. J., Nuijts, R. M. M. A., Geroski, D. H., Koole, L. H., Hendrikse, F., & Edelhauser, H. F. (2002) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076802321021108 · Cited by 77 · cited 1×
“In agreement with the previous study, Cruysberg and colleagues demonstrated that the permeability of sodium fluorescein across human sclera in an in vitro transport/diffusion experimental design is higher than that of rhodamine 6G (Cruysberg et al., 2002).”
ResultJani, P. D., Singh, N., Jenkins, C., Raghava, S., Mo, Y., Amin, S. H., Kompella, U. B., & Ambati, B. K. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0853 · Cited by 77
Self-citationKompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77
Self-citationFormulation of chitosan-DNA nanoparticles with poly(propyl acrylic acid) enhances gene expression
Kiang, T., Bright, C., Cheung, C., Stayton, P. S., Hoffman, A. S., & Leong, K. W. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/1568562042368112 · Cited by 76
Tyagi, P., Kadam, R. S., & Kompella, U. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048188 · Cited by 75
Self-citationFunctionalized nanosystems for targeted mitochondrial delivery
Durazo, S. A., & Kompella, U. B. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.11.001 · Cited by 73
Self-citationAyalasomayajula, S. P., & Kompella, U. B. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045231.51924.e8 · Cited by 69
Self-citationPermeability of Human Cornea and Sclera to Sulfonamide Carbonic Anhydrase Inhibitors
Edelhauser, H. F., & Maren, T. H. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060140266039 · Cited by 68
Chopra, P., Hao, J., & Li, S. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.032 · Cited by 67
Feasibility of Drug Delivery to the Posterior Pole of the Rabbit Eye with an Episcleral Implant
Kato, A., Kimura, H., Okabe, K., Okabe, J., Kunou, N., & Ogura, Y. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1258 · Cited by 66
Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice.
Kim, T., Lindsey, J. D., Aihara, M., Anthony, T. L., & Weinreb, R. N. (2002) · PubMed · Cited by 65
Duvvuri, S., Janoria, K. G., Pal, D., & Mitra, A. K. (2007) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.132 · Cited by 64
Nanoparticle-Mediated Delivery of shRNA.VEGF-A Plasmids Regresses Corneal Neovascularization
Qazi, Y., Stagg, B. C., Singh, N., Singh, S. R., Zhang, X., Luo, L., Simonis, J. M., Kompella, U. B., & Ambati, B. K. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9139 · Cited by 64
Self-citationTouchard, E., Berdugo, M., Bigey, P., El Sanharawi, M., Savoldelli, M., Naud, M.-C., Jeanny, J.-C., & Behar-Cohen, F. (2012) · Molecular Therapy · doi:10.1038/mt.2011.304 · Cited by 63 · cited 2×
“…a potential site of drug delivery for the treatment of posterior segment ocular disorders (Einmahl et al., 2002; Gilger et al., 2006; Gilger et al., 2010; Jiang et al., 2007; Jiang et al., 2009; Olsen et al., 2006; Olsen et al., 2011; Patel et al., 2011; Peden et al., 2011; Touchard et al., 2012).”
BackgroundPeden, M. C., Min, J., Meyers, C., Lukowski, Z., Li, Q., Boye, S. L., Levine, M., Hauswirth, W. W., Ratnakaram, R., Dawson, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017140 · Cited by 63
Friedburg, C., Thomas, M. M., & Lamb, T. D. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.t01-1-00217.x · Cited by 62
van der Merwe, S. M., Verhoef, J. C., Kotzé, A. F., & Junginger, H. E. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00152-8 · Cited by 62
Aukunuru, J., Ayalasomayajula, S. P., & Kompella, U. B. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021701 · Cited by 62
Self-citationDelivery from Episcleral Exoplants
Carvalho, R. A. P. D., Krausse, M. L., Murphree, A. L., Schmitt, E. E., Campochiaro, P. A., & Maumenee, I. H. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0030 · Cited by 60
Furrer, E., Berdugo, M., Stella, C., Béhar‐Cohen, F., Gurny, R., Feige, U., Lichtlen, P., & Urech, D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2370 · Cited by 59
Simon, B. H., Ando, H. Y., & Gupta, P. K. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841020 · Cited by 59
Periocular Triamcinolone for Prevention of Macular Edema after Plaque Radiotherapy of Uveal Melanoma
Horgan, N., Shields, C. L., Mashayekhi, A., Salazar, P. F., Materin, M. A., O’Regan, M., & Shields, J. A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.01.051 · Cited by 58
Single walled carbon nanotube reactivity and cytotoxicity following extended aqueous exposure
Panessa‐Warren, B. J., Maye, M. M., Warren, J. B., & Crosson, K. M. (2009) · Environmental Pollution · doi:10.1016/j.envpol.2008.12.028 · Cited by 54
Jin, J., Zhou, K., Park, K., Hu, Y., Xu, X., Zheng, Z. J., Tyagi, P., Kompella, U. B., & Ma, J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6229 · Cited by 53
Self-citationKim, H., Csaky, K. G., Gilger, B. C., Dunn, J. P., Lee, S. S., Tremblay, M., de Monasterio, F. M., Tansey, G., Yuan, P., Bungay, P. M., et al. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1076 · Cited by 52
Gene delivery nanoparticles fabricated by supercritical fluid extraction of emulsions
Mayo, A. S., Ambati, B. K., & Kompella, U. B. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.024 · Cited by 50
Self-citationIntraocular Penetration Kinetics of Prednisolone after Subconjunctival Injection in Rabbits
Tsuji, A., Tamai, I., & Sasaki, K. (2009) · Ophthalmic Research · doi:10.1159/000266253 · Cited by 48
Boddu, S. H. S., Jwala, J., Chowdhury, M. R., & Mitra, A. K. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0048 · Cited by 46 · cited 1×
“Furrer and colleagues demonstrated that a TNF-α inhibitory single-chain antibody fragment (scFv), was delivered to the vitreous, neural retina, and choroid-RPE of New Zealand White rabbits, after repeated topical administration of eye drops every hour up to 10 hours (Boddu et al., 2010).”
BackgroundAmaral, J., Fariss, R. N., Campos, M. M., Robison, W. G., Kim, H., Lutz, R., & Becerra, S. P. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0492 · Cited by 43
Surface‐functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium
Sundaram, S., Roy, S. K., Ambati, B. K., & Kompella, U. B. (2009) · The FASEB Journal · doi:10.1096/fj.09-129825 · Cited by 43
Self-citationCho, Y. K., Uehara, H., Young, J. R., Tyagi, P., Kompella, U. B., Zhang, X., Luo, L., Singh, N., Archer, B. J., & Ambati, B. K. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8393 · Cited by 39
Self-citationLiu, H., Meagher, C. K., Moore, C. P., & Phillips, T. E. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0280 · Cited by 36
pH-Dependent Disruption of Erythrocyte Membrane by Amphiphilic Poly(amino acid) Nanoparticles
Akagi, T., Kim, H., & Akashi, M. (2010) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856209x418519 · Cited by 36
Lee, T. W.-Y., & Robinson, J. R. (2004) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076804772745455 · Cited by 33
Liposome-bound cyclosporine: Clearance after intravitreal injection
Alghadyan, A. A., Peyman, G. A., Khoobehi, B., Milner, S., & Liu, K.-R. (1988) · International Ophthalmology · doi:10.1007/bf00137135 · Cited by 33
Gabhann, F. M., Demetriades, A. M., Deering, T. G., Packer, J. D., Shah, S. M., Duh, E. J., Campochiaro, P. A., & Popel, A. S. (2007) · Annals of Biomedical Engineering · doi:10.1007/s10439-006-9238-x · Cited by 30
Hydrogen Peroxide Damage to Human Corneal Epithelial Cells In Vitro
Tripathi, B. J. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070020590046 · Cited by 30
Fibrin Sealant for Retinoblastoma: Where Are We?
Martin, N., Kim, J. W., & Abramson, D. H. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2007.0110 · Cited by 29
TOXICITY AND CLEARANCE OF A COMBINATION OF LIPOSOME-ENCAPSULATED GANCICLOVIR AND TRIFLURIDINE
Peyman, G. A., Schulman, J. A., Khoobehi, B., Alkan, H., Tawakol, M. E., & Mani, H. (1989) · Retina · doi:10.1097/00006982-198909030-00012 · Cited by 27
Ruiz‐Moreno, J. M., Montero, J. A., Arias, L., Sanabria, M. R., Coco, R. M., da Silva, R. M., Araiz, J., Gómez‐Ulla, F., & García‐Layana, A. (2006) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2006.00691.x · Cited by 23
Perspectives on: Materials Aspects for Retinal Prostheses
Scholz, C. (2007) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911507082160 · Cited by 21
Schoenwald, R. D., Tandon, V., Wurster, D. E., & Barfknecht, C. F. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00166-5 · Cited by 19
Effect of Diabetes on Transscleral Delivery of Celecoxib
Cheruvu, N. P. S., Amrite, A. C., & Kompella, U. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9757-2 · Cited by 19
Self-citationUltra-high photosensitivity silicon nanophotonics for retinal prosthesis: Electrical characteristics
Khraiche, M. L., Lo, Y.-H., Wang, D., Cauwenberghs, G., Freeman, W. R., & Silva, G. A. (2011) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2011.6090807 · Cited by 18
Conjunctival M cells selectively bind and translocate Maackia amurensis leukoagglutinin
Meagher, C. K., Liu, H., Moore, C. P., & Phillips, T. E. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.11.005 · Cited by 18
Transfer of gene to human retinal pigment epithelial cells using magnetite cationic liposomes
Fujii, Y., Kachi, S., Itô, A., Kawasumi, T., Honda, H., & Terasaki, H. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.161109 · Cited by 14
Nanoparticles for Ocular Drug Delivery
Amrite, A. C., & Kompella, U. B. (2006) · doi:10.1201/9780849374555-13 · Cited by 14
Self-citationOphthalmic Applications of Nanotechnology
Raghava, S., Goel, G., & Kompella, U. B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-375-2_22 · Cited by 11
Self-citation(1989) · PubMed
Cited by
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Zhai, J., Fong, C., Tran, N., & Drummond, C. J. (2019) · ACS Nano · doi:10.1021/acsnano.8b07961 · Cited by 280
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Osborne, N. N., Núñez-Álvarez, C., Joglar, B., & del Olmo-Aguado, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.032 · Cited by 101
Metadata
- Authors
- Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 36
- Pages
- 172-198
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W1977190535
- Cited by
- 258
- References
- 167
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.